NTRA - Natera gains after company analyst defends following plunge on short report

Natera Inc. (NASDAQ:NTRA) shares rose 14%, paring almost half of the 33% decline on Wednesday, following a short report from Hindenburg Research on the diagnostics testing company. Several analysts on including Canaccord , Raymond James, Morgan Stanley and Baird came out in defense of Natera. The company on Thursday held a conference call with analysts and investors to address the allegations in the short report. "To put it mildly, we disagree with the characterization of the services we offer to physicians, as well as the law to which the Hindenburg report inaccurately sites," Natera CEO Steve Chapman said on the call, according to a transcript.  Chapman added later that the Hindenburg report is a "gross mischaracterization of the federal government's position." Morgan Stanley analyst Tejas Savant wrote in a note that the NTRA selloff presents a compelling buying opportunity as the concerns from the short report are likely overblown. The analyst has an

For further details see:

Natera gains after company, analyst defends following plunge on short report